Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 5.21% |
| CYNOSURE INC | CYNO | 4.42% |
| DAWSON GEOPH | DWSN | 4.33% |
| MARRIOTT VAC | VAC | 3.27% |
| BLOOMIN' | BLMN | 2.93% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Unisys Corporation ( UIS - Analyst Report ) recently completed the previously announced redemption of 12.5% senior notes worth $84.5 million due 2016.
Earlier on July25, 2012, the company announced that it will redeem $84.5 million of its 12.5% senior notes due January 2016. However, Unisys expects to incur a charge of approximately $6.4 million in the third quarter of 2012 related to this redemption. The debt reduction will result in an approximate $10 million decline in annual interest expense.
Additionally, Unisys intends to redeem $26,097,000 of the 12.5% senior notes that remain outstanding. These remaining notes will be redeemed at a price of 106.250% of their principal amount. The redemption will be completed on September 24, 2012.
In the first half of 2012, Unisys repaid a long-term debt worth $68.5 million. This comprises all of the remaining $25.5 million of its 14.25% senior secured notes due 2015, $40.0 million of its 12.5% senior notes due 2016 and $3.0 million of its 12.75% senior secured notes due 2014.
Unisys is consistently taking steps to reduce its debt, and targets a debt of $85 million by 2013 end. In 2011, Unisys reduced its debt by 56% or $464 million year over year to $360 million.
Unisys has also called for redemption of all $183,106,000 of its 12 3/4% senior secured notes due 2014. This redemption is expected to be completed on September 20, 2012.
These redemptions will result in an aggregate charge of approximately $23 million in the third quarter of 2012,
Last week, Unisys completed its previously announced offering of $210,000,000 of senior notes.
Management intends to use net proceeds from this offering to redeem all of the company's outstanding 12.75% senior secured notes due 2014, including payment of accrued interest and premium.
The macroeconomic conditions continue to be challenging for Unisys. We have a Neutral recommendation on the stock. The stock currently carries a Zacks #1 Rank, which translates into a short-term rating of Strong Buy.
Read the full reports :
Analyst Report on UIS